Peripheral Blood Stem Cell Mobilisation Following Bortezomib, Lenalidomide and Dexamethasone (VRD) Induction For Multiple Myeloma: Real World Single Centre Experience.

We conclude that successful PBSC mobilisation for at least one ASCT is possible after three cycles of VRd induction using G-CSF alone. The upfront use of cyclophosphamide-based mobilisation strategy has a role in patients who have had VRd induction, and where aim is to collect enough stem cells for two or more ASCT. This article is protected by copyright. All rights reserved.